Statistical Analysis Plan for the “Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-Infected Infants with Severe Pneumonia” Clinical Trial
June 12, 2025
The EMPIRICAL trial by Tisungane Mvalo, MD, aims to assess the safety and efficacy of an empirical treatment against cytomegalovirus (CMV) and tuberculosis (TB) compared to standard of care (SoC), on adverse events and 15-day and 1-year mortality among infants living with HIV hospitalized with severe pneumonia in Africa. Read...
